Bank Of America Corp Novavax Inc Call Options Transaction History

Bank Of America Corp

13 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$10.71 - $17.11 $34,272 - $54,752	-3,200 Reduced 1.57%	200,000 $2.53 Million
Q2 2024 Aug 14, 2024	SELL	$3.89 - $20.97 $1.45 Million - $7.8 Million	-372,100 Reduced 64.68%	203,200 $2.57 Million
Q1 2024 May 15, 2024	SELL	$3.76 - $6.02 $3.71 Million - $5.94 Million	-987,100 Reduced 63.18%	575,300 $2.75 Million
Q4 2023 Feb 14, 2024	BUY	$4.8 - $7.67 $4.45 Million - $7.11 Million	926,900 Added 145.85%	1,562,400 $7.5 Million
Q2 2023 Aug 14, 2023	BUY	$6.67 - $9.52 $1.74 Million - $2.48 Million	260,800 Added 69.6%	635,500 $4.72 Million
Q1 2023 May 12, 2023	SELL	$5.76 - $12.48 $1.9 Million - $4.11 Million	-329,300 Reduced 46.78%	374,700 $2.6 Million
Q4 2022 Feb 10, 2023	BUY	$8.86 - $25.04 $3.71 Million - $10.5 Million	418,900 Added 146.93%	704,000 $7.24 Million
Q3 2022 Nov 14, 2022	BUY	$18.2 - $76.12 $1.95 Million - $8.18 Million	107,400 Added 60.44%	285,100 $5.19 Million
Q2 2022 Aug 12, 2022	BUY	$36.28 - $75.29 $3.73 Million - $7.73 Million	102,700 Added 136.93%	177,700 $9.14 Million
Q1 2022 May 16, 2022	SELL	$69.73 - $142.9 $6.76 Million - $13.8 Million	-96,900 Reduced 56.37%	75,000 $5.52 Million
Q4 2021 Feb 08, 2022	BUY	$134.56 - $217.97 $22 Million - $35.7 Million	163,800 Added 2022.22%	171,900 $24.6 Million
Q3 2021 Nov 15, 2021	SELL	$177.8 - $270.58 $10.4 Million - $15.8 Million	-58,400 Reduced 87.82%	8,100 $1.68 Million
Q2 2021 Sep 13, 2021	BUY	$121.0 - $257.67 $8.05 Million - $17.1 Million	66,500 New	66,500 $14.1 Million

292

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $630M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.